At a glance
ClinicalIndex Comparison RecordN/ACompleted· 96 enrolled
Drug / intervention
Medlydevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Randomized Controlled Trial of a Mobile Phone-based Telemonitoring Application for Self-management and Clinical Decision Support for Patients With Complex Chronic Conditions
In Brief
A clinical study evaluating Medly for Heart Failure and 4 related conditions. Completed, enrolled 96 participants across 1 site.
Detailed Summary
Remote patient monitoring is a potential component for the management of chronic conditions that may provide reliable and real-time physiological measurements for clinical decision support, alerting, and patient self-management. The purpose of this study is to evaluate an UHN-built remote monitoring system for patients with complex chronic conditions called Medly.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHeart Failure, Chronic Obstructive Pulmonary Disease, Chronic Kidney Disease, Uncontrolled Hypertension, Diabetes
CountriesCanada
Collaborators--
Timeline
N/ACompletedFinished
2017201820192020202120222023202420252026
Enrollment StartAug 2016
First PostedApr 2017
Primary CompletionJun 2020
Study CompletionDec 2020
TodayJul 2026
First PostedApr 25, 2017
Enrollment StartAug 23, 2016
Primary CompletionJun 20, 2020
Study CompletionDec 15, 2020
TodayJul 2, 2026
Enrollment to primary: 3.8 yearsPosted 9.2 years ago
Interventions
Medlydevice